| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| clinical trials in nsclc | 0.55 | 0.6 | 3665 | 43 | 24 |
| clinical | 0.19 | 0.7 | 3270 | 57 | 8 |
| trials | 1.22 | 1 | 5860 | 16 | 6 |
| in | 1.43 | 0.9 | 5193 | 92 | 2 |
| nsclc | 0.94 | 0.6 | 7524 | 18 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| clinical trials in nsclc | 1.98 | 0.2 | 586 | 44 |
| nsclc stage 4 clinical trials | 1.58 | 0.6 | 6371 | 83 |
| nsclc lung cancer treatment clinical trials | 1.75 | 0.7 | 8662 | 91 |
| clinical trials for sclc | 1.6 | 0.7 | 8099 | 56 |
| current drugs approved for treatment of nsclc | 2 | 0.1 | 2309 | 17 |
| sclc definition and clinical trials | 1.3 | 0.5 | 1944 | 48 |
| new treatment for nsclc | 0.77 | 0.3 | 1282 | 42 |
| fda approved treatment for nsclc | 0.51 | 0.9 | 7225 | 54 |
| nsclc treatment algorithm 2021 | 0.6 | 1 | 8551 | 54 |
| trodelvy nsclc clinical trial | 0.21 | 1 | 4109 | 53 |
| nsclc treatment by stage | 0.6 | 0.4 | 3946 | 44 |
| nsclc treatment algorithm 2022 | 0.09 | 0.8 | 7708 | 64 |
| drugs approved for nsclc | 0.11 | 0.6 | 1371 | 16 |
| new treatments for nsclc cancer | 1.59 | 0.6 | 682 | 72 |
| treatment guidelines for nsclc | 2 | 0.1 | 7387 | 68 |
| targeted therapy for nsclc | 1.57 | 0.6 | 9436 | 34 |
| immunotherapy drugs for nsclc | 1.24 | 0.9 | 1948 | 83 |
| nsclc treatment guidelines nccn | 1.6 | 0.2 | 7660 | 34 |
| nsclc treatment guidelines australia | 1.2 | 0.5 | 7136 | 60 |
| nsclc second line treatment | 0.62 | 0.8 | 4107 | 63 |
| first line treatment of nsclc | 1.2 | 0.6 | 3495 | 5 |
| latest research and breakthroughs on nsclc | 1.04 | 1 | 521 | 94 |
